Studying how metabolic networks are affected by PHOSPHO1 inhibition—particularly when comparing healthy patients to those with diabetes or obesity—could affect disease understanding, diagnosis, and treatment methods. This evidence concerns the gene PHOSPHO1 and Obesity.